The second consignment of Oxford-AstraZeneca (Covishield) vaccine, purchased by Bangladesh government from the Serum Institute of India, will arrive in Dhaka on February 22.
Beximco Pharma-ceuticals Managing Director Nazmul Hasan came up with the disclosure while talking to reporters after receiving Covid-19 vaccine at Kurmitola General Hospital in the capital on Monday.He said 20-30 lakh doses of vaccine will arrive in Bangladesh from India on February 22.
“Now a little less amount of vaccine will come. I can’t say the exact amount. But 20-30 lakh doses of vaccine may come. It will depend on our demand. There is no chance of vaccine crisis,” he said.
Nazmul Hasan said no initiative has been taken yet to bring Covid-19 vaccine under private management as everyone is getting vaccine free of cost under the government’s vaccination programme.
On December 13, an agreement was signed for purchasing 30 million COVID-19 vaccine doses developed by the University of Oxford and AstraZeneca.
Under the agreement, Bangladesh government will buy 30 million vaccines from the Serum Institute of India through its local vendor Beximco Pharmaceuticals Limited.
On November 5, a tripartite Memorandum of Understanding (MoU) was signed for collecting three crore vaccine doses from the University of Oxford and AstraZeneca. The MoU was signed among the Bangladesh Government, Beximco Pharmaceuticals Ltd (BPL) and the Serum Institute of India (SII).On January 21, Bangladesh received two million doses of the Oxford-AstraZeneca COVID-19 vaccine as a gift from India, with the country planning to begin its mass vaccination early February.
A consignment of five million doses of Oxford-AstraZeneca ‘Covishield’ vaccine manufactured by the Serum Institute of India (SII) arrived from India on January 25.
Earlier on November 5 last year, the health ministry signed a tripartite Memorandum of Understanding with the Serum Institute in India and Beximco to import the vaccine developed by Oxford-AstraZeneca.